Precigen, Inc. (PGEN) financial statements (2022 and earlier)

Company profile

Business Address 20374 SENECA MEADOWS PARKWAY
GERMANTOWN, MD 20876
State of Incorp. VA
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1151007522274237238
Cash and cash equivalents4352661036863136
Short-term investments724891206175103
Receivables21202125384049
Inventory, net of allowances, customer advances and progress billings13111621202127
Inventory13111621202127
Disposal group, including discontinued operation 10111    
Other undisclosed current assets771116211710
Total current assets:157149235285154315324
Noncurrent Assets
Operating lease, right-of-use asset11925
Property, plant and equipment3435611291136543
Long-term investments and receivables49 1192953199
Long-term investments49 1192953199
Intangible assets, net (including goodwill)108120132279386383413
Goodwill545464150153157165
Intangible assets, net (excluding goodwill)546568129233226248
Restricted cash and investments   0   
Other noncurrent assets1212444
Other undisclosed noncurrent assets   2161130 
Total noncurrent assets:203166221431693634658
TOTAL ASSETS:360315456716847949982
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities28223245363132
Accounts payable55613985
Accrued liabilities1210122121168
Employee-related liabilities11814116719
Deferred revenue436
Debt00361101
Due to related parties0000000
Disposal group, including discontinued operation 1447    
Deferred revenue and credits435335
Contract with customer, liability16
Other undisclosed current liabilities23200107
Total current liabilities:354212362809576
Noncurrent Liabilities
Long-term debt and lease obligation192179210211888
Long-term debt, excluding current maturities183172186211888
Operating lease, liability10824
Liabilities, other than long-term debt26265157213278185
Deferred revenue and credits194257162
Deferred revenue232348
Contract with customer, liability54
Deferred tax liabilities, net 161722
Deferred income tax liabilities333
Other liabilities00 3341
Other undisclosed noncurrent liabilities   7  9
Total noncurrent liabilities:218205261276220285201
Total liabilities:253247384337300380277
Stockholders' equity
Stockholders' equity attributable to parent1076772363534560694
Additional paid in capital2,0231,8871,7521,7221,3971,3261,250
Accumulated other comprehensive income (loss)04(27)(29)(16)(36)(13)
Accumulated deficit(1,916)(1,823)(1,653)(1,331)(848)(729)(543)
Stockholders' equity attributable to noncontrolling interest   1613911
Total stockholders' equity:1076772379547569705
TOTAL LIABILITIES AND EQUITY:360315456716847949982

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues10410391161231191174
Revenue, net858186
Cost of revenue
(Cost of Goods and Services Sold)
    (33)(24)(23)
Gross profit:10410391161198167150
Operating expenses (10)(120)(666)(369)(316)(320)
Other undisclosed operating income    332423
Operating income (loss):10494(30)(506)(138)(125)(147)
Nonoperating income (expense)   (19)22(48)69
Investment income, nonoperating   1919102
Interest and debt expense   (9)(1)(1)(1)
Income (loss) from continuing operations before equity method investments, income taxes:10494(30)(533)(116)(174)(79)
Loss from equity method investments(0)(1)(7)(12)(14)(21)(9)
Other undisclosed income (loss) from continuing operations before income taxes(201)(196)(172)9111
Loss from continuing operations before income taxes:(97)(104)(209)(536)(130)(194)(87)
Income tax expense (benefit)0012234(1)
Loss from continuing operations:(97)(104)(208)(515)(127)(190)(88)
Income (loss) from discontinued operations5(67)     
Loss before gain (loss) on sale of properties:(92)(171)(208)(515)(127)(190)(88)
Other undisclosed net loss  (116)    
Net loss:(92)(171)(324)(515)(127)(190)(88)
Net income attributable to noncontrolling interest  251044
Net loss available to common stockholders, diluted:(92)(171)(322)(509)(117)(187)(84)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(92)(171)(324)(515)(127)(190)(88)
Other comprehensive income (loss)  1(13)21(23)(13)
Other undisclosed comprehensive income (loss)(4)31     
Comprehensive loss:(96)(139)(323)(528)(106)(214)(101)
Comprehensive income, net of tax, attributable to noncontrolling interest  261043
Comprehensive loss, net of tax, attributable to parent:(96)(139)(321)(522)(96)(210)(97)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: